This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. The early-stage pipeline for amyotrophic lateral sclerosis ...
Clinical Trials Arena on MSN
NeuroSense’s ALS drug improves survival in Phase IIb trial
NeuroSense is engaging with regulatory authorities to advance PrimeC into pivotal trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results